WeinbergerMHudgelDSpectorSChidseyC. Inhibition of theophylline clearance by troleandomycin. J Allergy Clin Immunol1977; 59: 228–31.
2.
RallTW. Central nervous system stimulants: The xanthines. In: GilmanAGGoodmanLSGilmanA, eds. The pharmacological basis of therapeutics, 6th ed.New York: Macmillan, 1980: 592–607.
3.
WeinbergerMHendelesLAhrensR. Pharmacological management of reversible obstructive airway disease. Med Clin North Am1980; 65: 579–613.
4.
KozakPCumminsLGillmanS. Administration of erythromycin to patients on theophylline. J Allergy Clin Immunol1977; 60: 149–51.
5.
La ForceCMillerMChaiH. Effect of erythromycin on theophylline clearance in asthmatic children. J Pediatr1981; 99: 153–6.
6.
PrinceRAWingDSHendelesLSWeinbergerMM. The effect of erythromycin base on theophylline kinetics (abstract). Drug Intell Clin Pharm1980; 14: 637.
7.
PrinceRAWingDSWeinbergerMMHendelesLSRiegelmanS. Effect of erythromycin on theophylline kinetics. J Allergy Clin Immunol1981; 68: 427–31.
8.
MayDCJarboeCHEllenburgDTRoeEJKariboJ. The effects of erythromycin on theophylline elimination in normal males. J Clin Pharmacol1982; 22: 125–30.
9.
PfeiferHJGreenblattDFriedmanP. Effects of three antibiotics on theophylline kinetics. Clin Pharmacol Ther1979; 26: 36–40.
10.
ZarowitzBSzeflerSJLasezkayGM. Effect of erythromycin base on theophylline kinetics. Clin Pharmacol Ther1981; 29: 601–5.
11.
KimelblattBJSlaughterRL. Lack of effect of intravenous erythromycin lactobionate on theophylline clearance. J Allergy Clin Immunol1980; 65: 313–4.
12.
MadduxMSLeedsNHOrganekHWHasegawaGRBaumanJL. The effect of erythromycin on theophylline pharmacokinetics at steady state. Chest1982; 81: 563–5.
13.
HemsworthTCRentonK. Depression of theophylline metabolism and elimination by troleandomycin and erythromycin. Biochem Pharmacol1981; 30: 1299–1304.
14.
IliopoulouAAldhousMEJohnstonATurnerP. Pharmacokinetic interaction between theophylline and erythromycin. Br J Clin Pharmacol1982; 14: 495–9.
15.
LepperMHDowlingHF. Treatment of pneumococcal meningitis with penicillin compared with penicillin plus aureomycin. Arch Intern Med1951; 88: 489–94.
16.
SandeMA. Antibiotic therapy of bacterial meningitis: Lessons we've learned. Am J Med1981; 71: 507–10.
17.
SimberkoffMSMoldoverNHRahalJJ. Absence of detectable bactericidal and opsonic activities in normal and infected human CSFs. J Lab Clin Med1980; 95: 362–72.
18.
RahalJJSimberkoffMS. Host defense and antimicrobial therapy in adult gram negative bacillary meningitis. Ann Intern Med1982; 96: 468–74.
19.
RahalJJSimberkoffMS. Bactericidal and bacteriostatic action of chloramphenicol against meningeal pathogens. Antimicrob Agents Chemother1979; 16: 13–8.
20.
LandesmanSHCorradoMLShahPMArmengaudMBarzaMCherubinCE. Past and current roles for cephalosporin antibiotics in treatment of meningitis. Am J Med1981; 71: 693–703.
21.
CorradoMLGombertMECherubinCE. Designing appropriate therapy in the treatment of gram negative bacillary meningitis. JAMA1982; 248: 71–4.
Drugs for treatment of systemic fungal infections.Med Lett Drugs Ther1982; 24: 36–8.
27.
MadduxMSBarriereSL. A review of complications of amphotericin B therapy: Recommendations for prevention and management. Drug Intell Clin Pharm1980; 14: 177–81.
28.
CarnecchiaBMKurtzkeJF. Fatal toxic reaction to amphotericin B in cryptococcal meningo-encephalitis. Ann Intern Med1960; 53: 1027–35.
29.
McDowellWB. Professional services department, E. R. Squibb (Dec)1982.
